Showing 96-100 of 138 clinical outcomes management & analytics:
Validation Of A Machine Learning Approach To Estimate Systemic Lupus Erythematosus Disease Activity Index Score Categories And Application In A Real-World Dataset

BMJ Journals Published: May 20, 2021 Read the Full Manuscript >>  Objective Use of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) in routine clinical practice is inconsistent, and availability of clinician-recorded SLEDAI scores in real-world datasets is limited. This study aimed to validate a machine learning model to estimate SLEDAI score categories using clinical notes[…]

OM1 Launches Multiple Sclerosis Registry With More Than 20,000 Patients Prospectively Followed With Deep Clinical Data

BOSTON, July 14, 2021 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, today announced the launch of its multiple sclerosis (MS) registry. MS is an auto-immune, inflammatory disease that attacks the central nervous system (CNS) and causes a variety of neurological symptoms, such as muscle weakness, spasticity, fatigue, numbness, vision[…]

CNS & Behavioral Health: Using RWD to Accelerate Research & Improve Outcomes

Tue, Jun 22, 2021 2:00 PM – 3:00 PM EDT Register >> Nearly 20% of Americans are diagnosed with a mental health condition every year. Yet, more than half of those don’t receive a treatment for their condition. Globally, neurological disorders are one of the leading causes of disability and death with few if any[…]

1 … 18 19 20 21 22 … 28